Publications by authors named "Andrea Quintana-Martinez"

Article Synopsis
  • The study aimed to analyze the clinical outcomes, comorbidities, and mortality rates of cancer patients infected with SARS-CoV-2 during the COVID-19 pandemic, along with the health protocols implemented in COVID care centers.!* -
  • Out of 1752 patients in a respiratory care unit, 5% had a prior cancer diagnosis with a distribution of 59.1% having solid tumors and 40.9% hematologic cancers; those with cancer showed lower ICU admission rates (8%) compared to non-cancer patients (17.4%).!* -
  • Despite their cancer status, hospitalized oncology patients with COVID-19 had similar survival rates as non-cancer patients, likely reflecting effective multidisciplinary care strategies
View Article and Find Full Text PDF
Article Synopsis
  • The study examines the incidence of venous thromboembolism (VTE) and bleeding events in patients with newly diagnosed multiple myeloma (MM) who received primary thromboprophylaxis, primarily using aspirin.
  • It finds that 14.8% of patients experienced VTE over the median follow-up of 19 months, with significant bleeding events reported in a small proportion of patients.
  • The study evaluates different thrombotic risk scores (TRSs) and concludes that while IMPEDE-VTE showed potential in differentiating risk levels, overall, the thrombotic risk scores did not effectively predict VTE or impact survival in MM patients.
View Article and Find Full Text PDF

Introduction: Patients with respiratory diseases face adverse situations such as symptom management, general condition deterioration, and a hostile perception of the hospital environment, favoring the appearance of anxiety and depression.

Methods: A total of 317 patients hospitalized for a disease of pulmonary origin were analyzed and divided into the following subgroups: infectious, oncological, acute, and chronic diseases. Patients over 18 years of age with preserved cognitive capacity were included in the study.

View Article and Find Full Text PDF

Extrapulmonary tuberculosis is defined as that case of tuberculosis clinically diagnosed and confirmed by bacteriological studies that affects tissues and organs outside the lung parenchyma. Mexico is in third place among Latin American countries in terms of the incidence of pulmonary and extrapulmonary tuberculosis. Culture methods are still the gold standard for the diagnosis of extrapulmonary tuberculosis since they identify the species and susceptibility to drugs.

View Article and Find Full Text PDF

Pulmonary histoplasmosis is caused by inhaling . Less than 1% develops the disease. Risk factors in immunocompetent individuals are environmental exposures in endemic areas.

View Article and Find Full Text PDF

Introduction: Pulmonary aspergilloma is commonly associated with comorbidities that cause immunodeficiency such as diabetes mellitus, tuberculosis, human immunodeficiency virus/acquired immunodeficiency syndrome and/or a pre-existing parenchymal lung disease such as chronic obstructive pulmonary disease. Predisposing factors can further increase the risk of acquiring this mycosis. Our objective was to determine the frequency, clinical and microbiological characteristics of pulmonary aspergilloma in immunocompromised patients.

View Article and Find Full Text PDF